The Pharmaceutical Industry in India has been a success story for the development of an Indigenous and self-reliant industry. The pharmaceutical sector of Indian economy is an imperative module of health system and planners fittingly acknowledged its role by awarding it the 1970 Patent Act. However the launching of economic reforms in 1990s, creation of WTO and implementation of TRIPS agreements in 2005 altered the economic paradigm of Indian Pharmaceutical Industry. The Act encouraged significant numbers of foreign pharmaceutical companies to participate in the Indian market and Indian Pharmaceutical Industry entered into a new era of competition and consolidation. The present work is the outcome of author's many years of research and an endeavor has been made to cover the latest pharmaceutical issues holistically and analytically. The book deals in burning subjects like Pharmaceutical R&D, Pharmaceutical FDI, Pharmaceutical Prices and problem of accessibility and impact of TRIPS on Indian Pharmaceutical Industry.